Categorized | Health, Safety

Pottsgrove Considers 'Impairing' Teen Drivers, For Safety's Sake

POTTSTOWN PA – Licensed drivers who are students in the Pottsgrove School District may have no real idea what it feels like to be behind a steering wheel and impaired by alcohol or drugs. The newest member of the Board of School Directors thinks it’s time they found out … safely, rather than tragically.

The PA-DUI Safety Bug is a modified Volkswagen Beetle.

Acting on a suggestion made to him by a district resident, director David Faulkner asked the board Tuesday (Sept. 28, 2010) to consider bringing “The Safety Bug” to a Pottsgrove school parking lot sometime in the near future. The modified Volkswagen Beetle automobile, developed by the Pennsylvania Driving Under The Influence Association, mimics the perils of impaired driving under controlled conditions.

It’s the car, not the driver, that’s drunk, according to the association. A supervisor who accompanies each driver sets the vehicle to behave unpredictably, creating “an unsettling episode for the teen in the driver’s seat who gains a first-hand glimpse of what it feels like to drive under the influence,” its promotional material said.

Faulkner’s fellow board members liked what they heard. In the district that, during the past 12 months, has openly grieved over the automobile accident-related deaths of several students, such an education could have long-lasting impact, they said.

The program, which includes the vehicle and staff time for set-up and supervision, costs $1,000 per day. Board President Michael Neiffer, for one, was undeterred by the cost. “A couple of thousand to educate our students this way? That’s a no-brainer,” he said.

For proper operation, The Safety Bug program requires a flat, paved parking lot of a specific size without obstructions. District Director of Facilities and Physical Plants Michael Katzenmoyer said the parking lot behind Pottsgrove Middle School, North Hanover Street, Potstown PA, probably best fit that description. The program, if held, could be conducted on a weekend to maximize attendance, directors speculated.

The program needs a prime sponsor too, and director April Kontostathis suggested the Pottsgrove High School’s SNAP Academy could fill that role. The student-run, teacher-mentored organization helps teens combat chemical dependency, tobacco use and a variety of other issues, and might be perfectly suited to promote the program, she said.

Despite their enthusiasm, board members made no decisions on scheduling the program. District Superintendent Dr. Bradley Landis said he would first discuss it with SNAP Academy representatives.

Faulkner joined the board in May (2010) to fill the unexpired term of director Robert Lindgren. Lindgren resigned to serve with U.S. armed forces in Afghanistan.

Related (to the Pottsgrove Board of School Directors’ Sept. 28 meeting):

Photo from padui.org

Sign up to get The Sanatoga Post delivered free daily by e-mail. Share this article.
See our galleries for photos that appear in The Post. Got news for us? E-mail The Post.
Find The Posts on Twitter, Facebook, Linked-In, Technorati, Flickr, YouTube, and RSS

Share

Comments are closed.

From Our Sponsors

RSS Health News

  • Follow-up Avastin shown to benefit colon cancer patients June 3, 2012
    CHICAGO (Reuters) - Colorectal cancer patients treated with a follow-up round of Avastin fare better than those given chemotherapy alone after their disease has worsened, according to results of a large clinical trial. […]
  • Armed antibody delays spread of certain breast cancers June 3, 2012
    CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs. […]
  • J&J hormone-blocking pill slows prostate cancer spread June 2, 2012
    CHICAGO (Reuters) - A trial of Johnson & Johnson's Zytiga in certain prostate cancer patients showed that it doubled the amount of time they lived without the disease getting worse, potentially offering new hope for patients who see their cancer return. […]
  • Bristol immune drug shows promise in three cancers June 2, 2012
    CHICAGO (Reuters) - An experimental Bristol-Myers Squibb drug helped shrink tumors in patients with advanced melanoma, kidney and lung cancers in a preliminary trial, raising hopes for yet another drug that can wake up the immune system and train it to attack cancer cells. […]
  • Hospitals fight drug scarcity, fear patients harmed June 2, 2012
    WASHINGTON (Reuters) - At the Henry Ford Hospital in Detroit, pharmacists are using old-fashioned paper spreadsheets to track their stock of drugs in short supply - a task that takes several hours each day. […]
  • Avastin delays progression of ovarian cancer June 2, 2012
    CHICAGO (Reuters) - Adding cancer drug Avastin to standard chemotherapy doubled the length of time a certain group of advanced ovarian cancer patients lived without their disease getting worse, according to results of a clinical trial. […]
  • U.S., Norway pledge $150 million for maternal health June 2, 2012
    OSLO (Reuters) - The United States and Norway each pledged on Friday to give in the range of $75 million to help protect mothers during labor, delivery and the first 24 hours after birth. […]
  • Walgreen, Express Scripts drop claims against each other June 1, 2012
    (Reuters) - Walgreen Co said on Friday that it and drug benefits manager Express Scripts Holding Co had dropped claims against each other stemming from a September 2011 lawsuit, but said the dismissals did not mean they were any closer to reaching a new deal. […]
  • Do doctor-payment sunshine laws work? June 1, 2012
    NEW YORK (Reuters Health) - The mere passage of a law that requires drug companies to disclose how much money they pay doctors may not change physician prescribing practices, suggests a new study. […]
  • Babies fed soy formula develop as well as others June 1, 2012
    NEW YORK (Reuters Health) - One-year-olds raised on breast milk, regular formula or soy formula seem to fare equally well in brain development, a new study suggests. […]